Sign In
Buy ADUS
$88.49
-1.96 (-2.17%)
At Close: Jun 03, 2026
ADUS or USPH: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 28'th Jan 2025
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two st
Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?
10:41am, Tuesday, 28'th Jan 2025
Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
03:46am, Friday, 17'th Jan 2025
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
11:10am, Thursday, 16'th Jan 2025
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poise
JMP Securities initiated coverage on Addus HomeCare Corp ADUS, a provider of home-based personal care and clinical services.
Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 05'th Dec 2024
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADUS vs. ASTH: Which Stock Is the Better Value Option?
12:41pm, Thursday, 05'th Dec 2024
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH). But which of these two sto
Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva
04:05pm, Monday, 02'nd Dec 2024
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced it has completed the acquisition of the personal care operations of Gentiva
Addus HomeCare to Participate in Stephens Annual Investment Conference
11:00am, Tuesday, 12'th Nov 2024
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, Pres
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
12:40pm, Friday, 08'th Nov 2024
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks p
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript
01:26pm, Tuesday, 05'th Nov 2024
Addus HomeCare Corporation (NASDAQ:ADUS ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief
Addus HomeCare (ADUS) Reports Q3 Earnings: What Key Metrics Have to Say
07:36pm, Monday, 04'th Nov 2024
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with W
Addus HomeCare (ADUS) Q3 Earnings and Revenues Surpass Estimates
07:01pm, Monday, 04'th Nov 2024
Addus HomeCare (ADUS) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.15 per share a year ago.
Addus HomeCare (ADUS) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Monday, 28'th Oct 2024
Addus HomeCare (ADUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks to Buy in an Evolving Outpatient Home Health Industry
12:05pm, Wednesday, 23'rd Oct 2024
Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised
